Philipp Kaldis has received his PhD from the Institute for Cell Biology, ETH (Swiss Federal Institute of Technology), Zürich, Switzerland, where he worked on the mitochondrial creatine kinase with Dr. Theo Wallimann and Dr. Hans Eppenberger. He has then joined Dr. Mark Solomon’s Laboratory at Yale University School of Medicine, Department of Molecular Biophysics and Biochemistry, New Haven, Connecticut, as a Postdoctoral Fellow/Associate Research Scientist to investigate the activation of cyclin-dependent kinases (Cdks). He has later joined the NCI-Frederick as Tenure-Track Investigator and was promoted to Senior Investigator with tenure in 2006. In 2007, he has joined the IMCB as a Senior Principal Investigator. His main research interests are cell cycle, cancer, metabolism, liver regeneration and cancer. Philipp Kaldis has received his PhD from the Institute for Cell Biology, ETH (Swiss Federal Institute of Technology), Zürich, Switzerland, where he worked on the mitochondrial creatine kinase with Dr. Theo Wallimann and Dr. Hans Eppenberger. He has then joined Dr. Mark Solomon’s Laboratory at Yale University School of Medicine, Department of Molecular Biophysics and Biochemistry, New Haven, Connecticut, as a Postdoctoral Fellow/Associate Research Scientist to investigate the activation of cyclin-dependent kinases (Cdks). He has later joined the NCI-Frederick as Tenure-Track Investigator and was promoted to Senior Investigator with tenure in 2006. In 2007, he has joined the IMCB as a Senior Principal Investigator. His main research interests are cell cycle, cancer, metabolism, liver regeneration and cancer.

biochemistry